🔍 📞 🔍
Main Menu

FDA revises Janssen COVID-19 vaccine fact sheets to reflect ITP risk

The fact sheets for healthcare providers and recipients and caregivers were revised in response to new safety information regarding the serious risk of Immune Thrombocytopenia, which can cause easy or excessive bruising and bleeding due to very low levels of platelets, following administration of the Janssen COVID-19 vaccine.

Published January 14, 2022